Synthesis of the chromone‐thiosemicarbazone scaffold as promising α‐glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202400140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Rima D Alharthy und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Science & Arts College, Rabigh Branch, King Abdulaziz University, Rabigh, Saudi Arabia. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, Hypoglycemic Agents, Drug Design, Molecular Docking Simulation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Diabetes is a serious metabolic disorder affecting individuals of all age groups and prevails globally due to the failure of previous treatments. This study aims to address the most prevalent form of type 2 diabetes mellitus (T2DM) by reporting on the design, synthesis, and in vitro as well as in silico evaluation of chromone‐based thiosemicarbazones as potential α‐glucosidase inhibitors. In vitro experiments showed that the tested compounds were significantly more potent than the standard acarbose, with the lead compound 3n exhibiting an IC 50 value of 0.40 ± 0.02 μM, ~2183‐fold higher than acarbose having an IC 50 of 873.34 ± 1.67 μM. A kinetic mechanism analysis demonstrated that compound 3n exhibited reversible inhibition of α‐glucosidase. To gain deeper insights, in silico molecular docking, pharmacokinetics, and molecular dynamics simulations were conducted for the investigation of the interactions, orientation, stability, and conformation of the synthesized compounds within the active pocket of α‐glucosidase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Science & Arts College, Rabigh Branch, King Abdulaziz University, Rabigh, Saudi Arabia.
- Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
- Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
- Natural and Medical Sciences Research Centre, University of Nizwa, Nizwa, Sultanate of Oman.
- Department of Pharmaceutical Science and Technology, Birla Institute of Technology, Mesra, India.
- Department of Medicinal Chemistry and Drug Discovery, Dr. Rajendra Gode Institute of Pharmacy, Amravati, India.
Zitieren
APA
Alharthy, R. D., Khalid, S., Fatima, S., Ullah, S., Khan, A., Mali, S. N., Jawarkar, R. D., Dhabarde, S. S., Kashtoh, H., Taslimi, P., Al-Harrasi, A., Shafiq, Z., & Boshta, N. M. (2024). Synthesis of the chromone‐thiosemicarbazone scaffold as promising α‐glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400140
Vancouver
Alharthy RD, Khalid S, Fatima S, Ullah S, Khan A, Mali SN, et al. Synthesis of the chromone‐thiosemicarbazone scaffold as promising α‐glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400140
BibTeX
@article{Alharthy2024,
author = {Alharthy, Rima D and Khalid, Sana and Fatima, Shamool and Ullah, Saeed and Khan, Ajmal and Mali, Suraj N and Jawarkar, Rahul D and Dhabarde, Sanjay S and Kashtoh, Hamdy and Taslimi, Parham and Al-Harrasi, Ahmed and Shafiq, Zahid and Boshta, Nader M},
title = {Synthesis of the chromone‐thiosemicarbazone scaffold as promising α‐glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202400140}
}
EUVIMED